Heritage Distilling (NASDAQ:IPST – Get Free Report) and Coeptis Therapeutics (NASDAQ:ZSQR – Get Free Report) are both small-cap technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership.
Earnings & Valuation
This table compares Heritage Distilling and Coeptis Therapeutics”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Heritage Distilling | $10.12 million | 0.20 | -$137.71 million | ($311.78) | -0.01 |
| Coeptis Therapeutics | $1.36 million | 114.96 | -$11.92 million | ($1.63) | -1.81 |
Analyst Recommendations
This is a breakdown of recent ratings for Heritage Distilling and Coeptis Therapeutics, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Heritage Distilling | 1 | 1 | 1 | 0 | 2.00 |
| Coeptis Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
Heritage Distilling presently has a consensus target price of $164.00, indicating a potential upside of 5,614.29%. Given Heritage Distilling’s stronger consensus rating and higher possible upside, research analysts clearly believe Heritage Distilling is more favorable than Coeptis Therapeutics.
Institutional & Insider Ownership
13.9% of Coeptis Therapeutics shares are held by institutional investors. 3.7% of Heritage Distilling shares are held by company insiders. Comparatively, 24.2% of Coeptis Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Heritage Distilling and Coeptis Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Heritage Distilling | -1,875.66% | -242.58% | -201.22% |
| Coeptis Therapeutics | -773.72% | -49.45% | -46.88% |
Risk & Volatility
Heritage Distilling has a beta of 5.41, suggesting that its share price is 441% more volatile than the S&P 500. Comparatively, Coeptis Therapeutics has a beta of -0.25, suggesting that its share price is 125% less volatile than the S&P 500.
Summary
Coeptis Therapeutics beats Heritage Distilling on 8 of the 14 factors compared between the two stocks.
About Heritage Distilling
Heritage Distilling Holding Company Inc. is a craft distiller of premium brands, including whiskeys, vodkas, gins, rums and ready-to-drink canned cocktails. Heritage Distilling Holding Company Inc. is based in GIG HARBOR, Wash.
About Coeptis Therapeutics
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Receive News & Ratings for Heritage Distilling Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heritage Distilling and related companies with MarketBeat.com's FREE daily email newsletter.
